Patent Yard Sign in
European application, no grantEurope

Procedure for producing a polypeptide-type product having an inhibiting effect on hyperproduction of the tumor necrosis factor

EP 0550376 A1 · Applicant: INDUSTRIA FARMACEUTICA CANTABRIA S.A.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed November 10, 1992 and never granted as a European patent. Had it been granted, its 20-year term would have ended November 10, 2012.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by May 10, 2018.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledNovember 10, 1992
PublishedJuly 7, 1993
GrantedNever granted
Term endedNovember 10, 2012
Application numberEP 92500145
Classification (CPC)C12N9/6481

Timeline

Timeline From EPO dates

1993199519971999200120032005200720092011Application filedNov 10, 1992PublishedJuly 7, 1993Term endedNov 10, 2012

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.